Haizhen Andrew Zhong, PhD

  • 851 Citations
  • 17 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 851 Citations
  • 17 h-Index
  • 37 Article
  • 4 Review article
  • 3 Editorial
  • 2 Chapter
Filter
Review article
2016

Advances in the development of class I phosphoinositide 3-kinase (PI3K) inhibitors

Sabbah, D. A., Hu, J. & Zhong, H. A., May 1 2016, In : Current Topics in Medicinal Chemistry. 16, 13, p. 1413-1426 14 p.

Research output: Contribution to journalReview article

17 Scopus citations
2011

Recent advances in small molecule inhibitors of VEGFR and EGFR signaling pathways

Zhong, H. & Phillip Bowen, J., Jun 1 2011, In : Current Topics in Medicinal Chemistry. 11, 12, p. 1571-1590 20 p.

Research output: Contribution to journalReview article

40 Scopus citations
2007

Molecular design and clinical development of VEGFR kinase inhibitors

Zhong, H. & Bowen, J. P., Jul 1 2007, In : Current Topics in Medicinal Chemistry. 7, 14, p. 1379-1393 15 p.

Research output: Contribution to journalReview article

53 Scopus citations
2006

Antiangiogenesis drug design: Multiple pathways targeting tumor vasculature

Zhong, H. & Bowen, J. P., Apr 1 2006, In : Current medicinal chemistry. 13, 8, p. 849-862 14 p.

Research output: Contribution to journalReview article

59 Scopus citations